Apple and Masimo’s legal battle over the Apple Watch’s Blood Oxygen sensing feature continues this week as both firms meet in ...

Apple and Masimo are back in a California court this week for a bench trial that will see Masimo arguing that Apple illegally ...

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

The healthcare sector depends on medical technology advancements, particularly devices used in disease prevention, diagnosis, ...

One of the most helpful features on Apple Watches, blood oxygen tracking, remains MIA on watches sold after January. Here's ...

Apple won the case, though was only awarded a nominal $250, which is the smallest amount it was possible for the court to order. In other words, yes Masimo did in infringe Apple’s patents, but there ...

A federal jury awarded Apple a nominal $250 in damages in its ongoing legal battle with Masimo, the medical technology ...

Apple's legal team argued that Masimo had copied the Apple Watch's design and functionality, focusing on the device's aesthetic appeal rather than its innovative pulse oximetry technology.

A Delaware jury has found health tech company Masimo guilty of infringing Apple’s Apple Watch patents on health technology, but limited it to only older smartwatch models that are no longer sold, and ...

The US International Trade Commission (ITC) ruled that Apple’s smartwatch models, including the Watch Series 9 and Ultra 2, infringed upon Masimo’s blood-oxygen technology patents. This decision led ...

Apple wins a symbolic $250 in damages as a federal jury finds that Masimo's smartwatch designs and charger infringe on Apple Watch patents. Despite the minimal monetary award, Apple claims the ...

which started with the Masimo’s claim that its patents had been infringed by the Apple Watch’s pulse-oximetry feature, which allows Watch owners to measure their blood oxygen levels. Apple disabled ...